[Immunopotentiating effect of a chemotherapeutic agent (Neocarzinostatin). Accumulation of macrophages during intrathecal administration].
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D001921:Brain / Q000473:pathology; D002528:Cerebellar Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002675:Child, Preschool; D003131:Combined Modality Therapy; D006168:Guinea Pigs; D006801:Humans; D007278:Injections, Spinal; D008264:Macrophages / Q000187:drug effects*; D008297:Male; D008527:Medulloblastoma / Q000188:drug therapy* / Q000473:pathology; D009353:Zinostatin / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D000903:Antibiotics, Antineoplastic; D009353:Zinostatin